Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18638004rdf:typepubmed:Citationlld:pubmed
pubmed-article:18638004lifeskim:mentionsumls-concept:C0242350lld:lifeskim
pubmed-article:18638004lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18638004lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:18638004lifeskim:mentionsumls-concept:C1318700lld:lifeskim
pubmed-article:18638004lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:18638004lifeskim:mentionsumls-concept:C2353244lld:lifeskim
pubmed-article:18638004pubmed:issue11lld:pubmed
pubmed-article:18638004pubmed:dateCreated2008-11-13lld:pubmed
pubmed-article:18638004pubmed:abstractTextMirodenafil is a newly developed oral phosphodiesterase type 5 inhibitor, currently under investigation as a treatment for erectile dysfunction (ED).lld:pubmed
pubmed-article:18638004pubmed:languageenglld:pubmed
pubmed-article:18638004pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18638004pubmed:citationSubsetIMlld:pubmed
pubmed-article:18638004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18638004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18638004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18638004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18638004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18638004pubmed:statusMEDLINElld:pubmed
pubmed-article:18638004pubmed:monthNovlld:pubmed
pubmed-article:18638004pubmed:issn1743-6109lld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:LeeSung WSWlld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:ParkKwangsung...lld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:SuhJun-KyuJKlld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:PaickJae-Seun...lld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:HUSSGGlld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:ChungWoo-SikW...lld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:KimSae CSClld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:JungHyung-GiH...lld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:AhnTai YTYlld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:ChoiHyung KHKlld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:KimSae WSWlld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:MinKweon SKSlld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:MoonKi HKHlld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:ParkJong KJKlld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:ParkNam CNClld:pubmed
pubmed-article:18638004pubmed:authorpubmed-author:YangDae YDYlld:pubmed
pubmed-article:18638004pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18638004pubmed:volume5lld:pubmed
pubmed-article:18638004pubmed:ownerNLMlld:pubmed
pubmed-article:18638004pubmed:authorsCompleteYlld:pubmed
pubmed-article:18638004pubmed:pagination2672-80lld:pubmed
pubmed-article:18638004pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:meshHeadingpubmed-meshheading:18638004...lld:pubmed
pubmed-article:18638004pubmed:year2008lld:pubmed
pubmed-article:18638004pubmed:articleTitleEfficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction.lld:pubmed
pubmed-article:18638004pubmed:affiliationDepartment of Urology, Seoul National University Hospital, Seoul, Korea. jspaick@snu.ac.krlld:pubmed
pubmed-article:18638004pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18638004pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:18638004pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:18638004pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18638004pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18638004lld:pubmed